Literature DB >> 15572670

C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes.

Kyungsil Yoon1, Robert C Smart.   

Abstract

The basic leucine zipper transcription factor, CCAAT/enhancer binding protein alpha (C/EBPalpha), is abundantly expressed in keratinocytes of the skin; however, its function in skin is poorly characterized. UVB radiation is responsible for the majority of human skin cancers. In response to UVB-induced DNA damage, keratinocytes activate cell cycle checkpoints that arrest cell cycle progression and prevent replication of damaged DNA, allowing time for DNA repair. We report here that UVB radiation is a potent inducer of C/EBPalpha in human and mouse keratinocytes, as well as in mouse skin in vivo. UVB irradiation of keratinocytes resulted in the transcriptional up-regulation of C/EBPalpha mRNA, producing a >70-fold increase in C/EBPalpha protein levels. N-Methyl-N'-nitro-N-nitrosoguanidine, etoposide, and bleomycin also induced C/EBPalpha. UVB-induced C/EBPalpha was accompanied by an increase in p53 protein and caffeine, an inhibitor of ataxia-telangiectasia-mutated kinase, and ataxia-telangiectasia-mutated and Rad3-related kinase inhibited UVB-induced increases in both C/EBPalpha and p53. UVB irradiation of p53-null or mutant p53-containing keratinocytes failed to induce C/EBPalpha. UVB irradiation of C/EBPalpha knockdown keratinocytes displayed a greatly diminished DNA damage G(1) checkpoint, and this was associated with increased sensitivity to UVB-induced apoptosis. Our results uncover a novel role for C/EBPalpha as a p53-regulated DNA damage-inducible gene that has a critical function in the DNA damage G(1) checkpoint response in keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572670      PMCID: PMC533967          DOI: 10.1128/MCB.24.24.10650-10660.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  p53-independent regulation of cyclin B1 in normal human fibroblasts during UV-induced G2-arrest.

Authors:  F Vincent; G Deplanque; J Ceraline; B Duclos; J P Bergerat
Journal:  Biol Cell       Date:  1999-12       Impact factor: 4.458

2.  E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo.

Authors:  B T Porse; X Xu; B Lindberg; U M Wewer; L Friis-Hansen; C Nerlov
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

Review 3.  Post-translational modifications and activation of p53 by genotoxic stresses.

Authors:  E Appella; C W Anderson
Journal:  Eur J Biochem       Date:  2001-05

4.  Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.

Authors:  J E Hulla; J E French; J K Dunnick
Journal:  Carcinogenesis       Date:  2001-01       Impact factor: 4.944

5.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.

Authors:  T Pabst; B U Mueller; P Zhang; H S Radomska; S Narravula; S Schnittger; G Behre; W Hiddemann; D G Tenen
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

6.  Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.

Authors:  L Xu; L Hui; S Wang; J Gong; Y Jin; Y Wang; Y Ji; X Wu; Z Han; G Hu
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

Review 7.  UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer.

Authors:  F R de Gruijl; H J van Kranen; L H Mullenders
Journal:  J Photochem Photobiol B       Date:  2001-10       Impact factor: 6.252

8.  CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding.

Authors:  T E Harris; J H Albrecht; M Nakanishi; G J Darlington
Journal:  J Biol Chem       Date:  2001-05-21       Impact factor: 5.157

9.  C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription.

Authors:  B A Slomiany; K L D'Arigo; M M Kelly; D T Kurtz
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

10.  CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein.

Authors:  N A Timchenko; M Wilde; M Nakanishi; J R Smith; G J Darlington
Journal:  Genes Dev       Date:  1996-04-01       Impact factor: 11.361

View more
  36 in total

1.  Upregulation of C/EBPα contributes to colorectal cancer growth, metastasis and indicates poor survival outcome.

Authors:  Lan Mi; Kai Hu; Xianzi Wen; Jing Sun; Aiwen Wu; Mingliang Wang; Minhua Zheng; Lu Zang; Jiafu Ji
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  C/EBPα expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBPα confers susceptibility to UVB-induced skin squamous cell carcinomas.

Authors:  Elizabeth A Thompson; Songyun Zhu; Jonathan R Hall; John S House; Rakesh Ranjan; Jeanne A Burr; Yu-Ying He; David M Owens; Robert C Smart
Journal:  J Invest Dermatol       Date:  2011-02-24       Impact factor: 8.551

3.  Drosophila IRBP bZIP heterodimer binds P-element DNA and affects hybrid dysgenesis.

Authors:  Malik Joseph Francis; Siobhan Roche; Michael Jeffrey Cho; Eileen Beall; Bosun Min; Ronaldo Paolo Panganiban; Donald C Rio
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

Review 4.  A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.

Authors:  A R Lourenço; P J Coffer
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

Review 5.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

6.  C/EBPα regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint.

Authors:  Jonathan R Hall; Michael S Bereman; Angelito I Nepomuceno; Elizabeth A Thompson; David C Muddiman; Robert C Smart
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.

Authors:  Ji Suk Chang; Ramasamy Santhanam; Rossana Trotta; Paolo Neviani; Anna M Eiring; Edward Briercheck; Mattia Ronchetti; Denis C Roy; Bruno Calabretta; Michael A Caligiuri; Danilo Perrotti
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

8.  Protein kinase Cdelta stimulates proteasome-dependent degradation of C/EBPalpha during apoptosis induction of leukemic cells.

Authors:  Meng Zhao; Xu-Fang Duan; Xu-Yun Zhao; Bo Zhang; Ying Lu; Wei Liu; Jin-Ke Cheng; Guo-Qiang Chen
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

9.  C/EBPalpha and C/EBPbeta are required for Sebocyte differentiation and stratified squamous differentiation in adult mouse skin.

Authors:  John S House; Songyun Zhu; Rakesh Ranjan; Keith Linder; Robert C Smart
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

10.  C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint.

Authors:  R Ranjan; E A Thompson; K Yoon; R C Smart
Journal:  Oncogene       Date:  2009-07-06       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.